EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE

Fengyi Sun, Tiantian Zhao

Cancer Biomarkers · 2024

DOI: 10.3233/cbm-240074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Fengyi Sun und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Proto-Oncogene Proteins c-akt, Kinesins, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cervical cancer is a prevalent malignancy that significantly contributes to morbidity and mortality rates among women in developing nations. Although the association of KIF18A with various cancers has been established, its role in cervical squamous cell carcinoma (CESC) remains elusive. METHODS: The KIF18A impact on the progression of CESC and its underlying mechanism were investigated through comprehensive bioinformatics analysis utilizing publicly available datasets. The levels of KIF18A and CENPE were assessed in clinical CESC samples through western blotting and qRT-PCR. To discover the role and molecular pathways of KIF18A in CESC, a combination of experimental approaches, including wound-healing, flow cytometry, CCK-8, and Transwell assay, were employed. RESULTS: Our results demonstrate a significant KIF18A expression upregulation in CESC tissues in contrast to healthy tissues. In vitro, KIF18A upregulation was found to enhance cell growth, migration, and invasion and activate the PI3K/AKT signaling pathway while concurrently suppressing apoptosis. Conversely, downregulating KIF18A exhibited contrasting effects. Mechanistically, we observed a positive significant connection between KIF18A and CENPE in CESC cells. CONCLUSION: KIF18A promotes tumor growth in CESC by modulating the PI3K/AKT signaling pathway through regulation of CENPE, making it a potential biomarker for diagnosis and prognosis as well as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsProto-Oncogene Proteins c-aktKinesinsPhosphatidylinositol 3-KinasesCarcinoma, Squamous CellSignal TransductionUp-RegulationDisease ProgressionHumansFemaleCell Line, TumorCell ProliferationCell MovementGene Expression Regulation, NeoplasticApoptosisBiomarkers, Tumor

Stichwörter der Autor:innen

CENPECervical squamous cell carcinomaKIF18API3K/AKT pathway

Substanzen

Proto-Oncogene Proteins c-aktKinesinsPhosphatidylinositol 3-KinasesKIF18A protein, humanBiomarkers, Tumor

Zitieren

APA

Sun, F., & Zhao, T. (2024). KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE. Cancer Biomarkers. https://doi.org/10.3233/cbm-240074

Vancouver

Sun F, Zhao T. KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE. Cancer Biomarkers. 2024. doi:10.3233/cbm-240074

BibTeX
@article{Sun2024,
  author = {Sun, Fengyi and Zhao, Tiantian},
  title = {KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE},
  journal = {Cancer Biomarkers},
  year = {2024},
  doi = {10.3233/cbm-240074}
}
Kostenlos starten →